IDEXX Laboratories, Inc.
IDXX
$579.85
$2.730.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.42% | 8.39% | 6.68% | 5.56% | 6.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.42% | 8.39% | 6.68% | 5.56% | 6.46% |
| Cost of Revenue | 8.27% | 5.62% | 3.64% | 2.55% | 3.24% |
| Gross Profit | 11.80% | 10.18% | 8.68% | 7.55% | 8.63% |
| SG&A Expenses | 7.23% | 8.11% | 6.78% | 5.42% | 7.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.38% | 7.11% | 5.40% | 4.42% | 5.61% |
| Operating Income | 15.06% | 11.31% | 9.64% | 8.22% | 8.45% |
| Income Before Tax | 19.31% | 16.51% | 15.60% | 3.26% | 4.59% |
| Income Tax Expenses | 19.26% | 8.51% | 11.83% | 3.18% | 2.70% |
| Earnings from Continuing Operations | 19.33% | 18.61% | 16.56% | 3.28% | 5.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.33% | 18.61% | 16.56% | 3.28% | 5.07% |
| EBIT | 15.06% | 11.31% | 9.64% | 8.22% | 8.45% |
| EBITDA | 14.73% | 11.30% | 10.05% | 8.87% | 8.89% |
| EPS Basic | 22.39% | 21.44% | 18.84% | 4.66% | 5.82% |
| Normalized Basic EPS | 16.75% | 12.94% | 11.37% | 10.31% | 11.15% |
| EPS Diluted | 22.57% | 21.72% | 19.03% | 4.84% | 6.06% |
| Normalized Diluted EPS | 16.99% | 13.18% | 11.60% | 10.53% | 11.32% |
| Average Basic Shares Outstanding | -2.47% | -2.25% | -1.82% | -1.28% | -0.72% |
| Average Diluted Shares Outstanding | -2.67% | -2.46% | -2.02% | -1.48% | -0.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |